NetworkNewsBreaks – Earth Science Tech, Inc. (ETST) Provides Update on CBD Formula Patents, Medical Device Progress

June 7, 2018 09:12:24

Earth Science Tech (OTC: ETST), an innovative biotech company focused on the cannabidiol (“CBD”), nutraceutical and pharmaceutical fields, this morning provided an update regarding its ongoing CBD formula patents and medical device progress. Per the update, the prototyping of three CBD formula patents, which the company received a grant from the Government of Quebec to develop, has begun. The initial batch will be tested by the team and in vitro testing is expected to begin in summer 2019 to demonstrate the superior antioxidant activities and improved anti-proliferative effects on breast cancer cells. The third product is a superfood edible that is anticipated to be ready for Q4 of 2018. In addition, the company reported that it is currently working with Accélération, Design et Innovation Inc. regarding the final packaging of its MSN-2 medical device in preparation of its upcoming launch. “The official launch of this medical device is a little like giving birth. It will be unique in the marketplace and we are branding this device globally. The commercial name will be announced soon, as we are in the process of trademark protection for the logo and name. We will create a strong demand for this medical device by showing the world its powerful capacity to diminish the prevalence of chlamydia and other Sexually Transmitted Infections,” Earth Science Tech CEO and Chief Science Officer Dr. Michel Aubé stated in the news release.

To view the full press release, visit

About Earth Science Tech, Inc.

Earth Science Tech, Inc. offers the highest purity and quality high-grade full spectrum cannabinoid oil on the market. There are positive results in studies on breast cancer and immune cells through the University of Central Oklahoma, and studies through DV Biologics prove it lowers cortisol and functions as a neuro-protectant, with positive result case studies through key health organizations. ETST formulates, markets, and distributes the CBD oil used for its studies to the public, offering the most effective quality of CBD on the market. For more information, visit the company’s website at

More from NetworkNewsBreaks

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, please visit

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published:

NetworkNewsWire (NNW)
New York, New York
212.418.1217 Office